IMPORTANT DEVELOPMENTS 1/23/06

TOUGH FILTER  1/18/06

THE SELL OFF OF DNA AND OTHER NEWS 1/12/06

AT THE FINISH LINE 1/3/06

CELGENE< MEDIMMUNE AND OTHER NEWS 12/28/05

IT'S ALL ABOUT PROGENICS 12/23/05

PHARMACOGENOMICS FIRMS IN MOTION 12/20/05

TODAY'S IMPACTING ACTIVITIES 12/19/05

CRXL, CRIS, AND STAPH STORY 12/16/05

CONGRATU:LATION ANOTHER TIME 12/15/05

FILTERING 12/14/05 NEWS

FOLLOWING PATHWAYS, NOT SERENDIPITY 12/6/05

AS ANNOUNCED, IT LOOKS GOOD 12/5/05

RIGEL: A GREAT DISAPPOINTMENT 12/1/05

AGREEMENTS - PROOF OF CONCEPT 11/30/05

THE FILTER OF NEWS 11/29/05

HAPPY THANKSGIVING AND ASSESSING IS THE TOPIC 11/23/05

BIIB AND ELN STARS AGAIN 11/18/05

EYE ON GTOP, GILD AND INHX 11/16/05

AMGEN, OSI AND AVII 11/14/05

CTIC: GOOD RESULTS ON INDOLENT LYMPHOMA 11/10/05

INTROGEN"S MOUTHWASH? 11/7/05

THE TOP-TIER AND OTHERS 11/4/05

EXCELLENT IMPACTING NEWS 11/3/05

CHIRON (ANOTHER OFFER FROM NOVARTIS) AND ALNYLAM 10/31/05

CHIR, AMGN, FLML, 10/28/05

OVARIAN CANCER: GOOD NEWS? 10/25/05

ASSESSING THE KING? 10/21/05

SERIES OF GOOD NEWS 10/20/05

GENTA, SAMARITAN AND ALFACEL 10/19/05

KOSAN (KOSN):A PARTIAL SETBACK THAT COULD BE EXAGGERATED 10/18/05

MILLENNIUM (10/17/05

TYSABRI, BIIB AND ELN, MEMY 10/17/05

MEDIMMUNE, MEDAREX, CURIS AND.. 10/14/05

GENENTECH THE KING 10/11/05

ANTIGENICS AND BIOCRYST 10/10/05

TOLL LIKE RECEPTOR HIGHLIGHTED. HGSI TO LOSE 10/5/05

VERTEX DID IT AGAIN. CANCERVAX SETBACK 10/4/05

THE IMPACT OF READING ALL THIS NEWS 9/30/05

PERSONALIZED MEDICINE IS IN.  GENZ, OSI  9/27/05

GENTA: IMPORTANT NEWS 9/19/05

PROHOST FILTER 9/19/05

OSIP, EYET, GERN, GENZ 9/16/05

TARCEVA RECOMMENDED FOR APPROVAL AND ANOTHER INDICATION FOR HERCEPTIN 9/14/05

▲RNA-SPECIALIZED FIRMS AND MORE GOOD NEWS 9/7/05

CV THERAPEUTICS, OXiGENE, THIRD WAVE THERAPEUTICS AND ADOLOR  8/24/05

ASSESSMENT, OSI AND CASE BY CASE NEWS 8/23/05

OSI ACQUIRES EYETECH. GOOD OR BAD? 8/22/05

SPEEDING THE EVOLUTION 8/18/05

VIROPHARMA: WORTH EXAMINING? 8/5/05

BLINDNESS: A BREAKTHROUGH  DISCOVERY 8/17/05

NEWS ABOUT A TECHNOLOGY 8/10/05

TYSABRI AGAIN AND XOMA 8/9/05

OPPORTUNITIES THAT WE TALKED ABOUT 8/8/05

COLLABORATION 8/5/05

PROTEIN DESIGN 8/4/05

WHEN QUARTERLY REPORTS MEAN A LITTLE 7/29/05

GETTING EXCITED ABOUT NONSENSE 7/28/05

NICE TO HEAR FROM MYVAX 7/26/05

MILLENNIUM 7/25/05

THE SLAUGHTER OF AN EXCELLENT STOCK 7/22/05

ABOUT APHTON'S CANCER DRUG 7/22/05

DENDREON: PROVENGE EXTENDS LIVES 7/21/05

BETTER BE INFORMED 7/21/05

SIDE EFFECTS AND LABELS 7/20/05

WHO IS THE DREAMER? 7/20/05

AMGEN SOARS. DO YOU KNOW NOW WHAT WE MEAN? 7/19/05

EXCELLENCE, FINANCING, AND ROYALTY PURCHASE 7/19/05

EYE ON GERON 7/18/05

GOOD NEWS, SETBACKS AND PERFORMING FIRMS 7/18/05

WiNNERS TO GROW AND WINNERS TO CONTINUE WINNING 7/15/05

CRXL AND OSIP GOOD NEWS 7/14/05

UPGRADED 7/13/05

KIDNEY CANCER, AIDS AND OSTEOPOROSIS 7/11/05

ENTREMED AND BIOSANTE 7 7 05

GTC (GTCB) CRITICAL TIMES 7 7 05

GENAISSANCE AND OTHER INTERESTING NEWS 7/5/05

HAS GENTA  DRUG, GENASENSE, BEEN RESURRECTED?  6/30/05

MILLENNIUM  6/29/05

CUBIST: NEWS THAT CAME ON TIME 6/28/05

PROHOST NEWS FILTER 6/27/05

PDLI, XOMA, IMNR 6/22/05

CONGRATULATION ON MICU 6/17/05

IMPACTING NEWS OF THE DAY 6/15/05

HOW IMPACTING? 6/14/05

BREAKTHROUGHS AND EXCELLENT NEWS 6/3/05

GOOD NEWS ON BRAIN CANCER, XOMA AND HYBRIDON 6/1/05

ABOUT ASCO AND ABOUT BIIB 5/17/05

GENTA 5/13/05

XOMA, ARRAY, VERTEX AND GERON 5/10/05

EXELIXIS 5/9/05

DYAX, MLNM, CRXL 4/29/05

GOOD NEWS AND A SMALL SETBACK 4/27/05

THE ONE. BUT NOT THE ONLY.4/26/05

MILLENNIUM AND VELCADE 4/25/05

TARCEVA AGAIN AND XOMA 4/19/05

CANCER, CANCER, CANCER 4/15/05

GENENTECH AND SIRNA 4/12/05

GOOD NEWS FOR CTIC 4/11/05

DIVERSA, GENENTECH AND CELGENE 4/11/05

SUCCESSES, SETBACKS AND THE BIG QUESTION 4/7/05

XOMA: WHY THE SURGE IN THE STOCK?  4/6/05

EYE ON AND.. TYSABRI 4/6/05

TYSABRI 3/31/05

BAD NEWS FOR LIGAND AND OTHER NEWS 3/28/05

VELCADE'S NEW APPROVAL

 CYTO AND CRGN 3/25/05

SETBACKS AND DISCOVERIES 3/24/05

BIOTECHNOLOGY AND IMMMUNITY 3/23/05

CANCER AND CANCER 3/22/05

TECHNOLOGIES AND PRODUCTS 3/18/05

APPROVAL, DISCOVERY AND GENE THERAPY 3/17/05

GOOD AND BAD NEWS 3/14/05

XOMA, TEVA   3/11/05

deCODE, DIVERSA, AND.. 93/9/05

GOOD, BAD, OR EARLY TO SAY? 3/8/05

SUCCESSFUL THERAPIES 3/7/05

BIIB, ELN, CBST, MICU 3/4/05

CHIR, CYTO, CRIS, FMTI 3/2/05

EYE ON BIIB AND ELAN  3/1/05

EYE ON BIIB, IDEC AND OMY  2/28/05

EYE ON YM BIOSCIENCES (YMI)  2/28/05)

EYE ON GENZ, KOSN, ALT 2/25/05

EYE ON DNA AND GERN 2/23/05

EYE ON BIOM, DNDN, MLNM 2/22/05

EYE ON DNDN, BIIB AND ELN 2/17/05

EYE ON NBIX, CEPH, CRXL, PDLI 2/16/05

EYE ON TELK, DSCO, CELG, ISPH 2/10/05

EYE ON SQNM, IMA 2/9/05

EYE ON SQNM IMA 2/9/05

EYE ON GENZ,ELN,CRXA AND AFFX 2/8/05

CYBX , ELN, MEDI NSTK PDLI  2/3/05

ZILA AND VALEANT? 2/2/05

VELCADE AND OTHER NEWS 1/2/05

TODAY'S EYE ON UPDATED 1/31/05

TODAY'S EYE ON 1/31/05

DOING WELL AND GETTING HIT BY THE F 1/28/05

AASTROM'S RESPONSE TO ACCUSATIONS 1/25/05

DNA TEST, IMMUNOTHERAPY, ALLIANCE AND CLARIFICATION BY XOMA 1 21 05

XOMA'S GOOD NEWS 1/13/05

ACQUISITIONS AND A GROWING FIRM 1/5/05

BAD, GOOD AND FRUSTRATING NEWS 1/4/05

HAPPY NEW YEAR  1/2/05

CASUALTIES OF COX2 AND OTHER FIRMS 12/22/04

XOMA, GESC, ENZN, GILD 12/21/04

CONGRATULATION PROHOST SUBSCRIBERS 12/17/04

AMGEN, SEPRACOR AND MORE  12/16/04

GOOD NEWS ONLY 12/13/04

SYNOPSIS 12/8/04

SYNOPSIS 12/7/04

GOOD NEWS FROM TELIK AND BIOMARIN 12/6/04

XOMA AND BIOMIRA: GOOD NEWS 12/3/04

APPROVAL OF A GREAT DRUG AND .11/24/04

AS WE TOLD YOU IN THE NEWSLETTER 11/22/04

TARCEVA APPROVED 11/19/04

FROM THE ASTHMA MEETING 11/15/04

IT'S ALL ABOUT VACCINES 11/12/04

WE LIKE WHAT WE SEE  11/11/04

UNTIL TOMORROW, THIS IS TODAY 11/9/04

MORE GOOD NEWS FOR MLNM 11/8/04

MILLENNIUM: VELCADE VELCADE VELCADE 11/3/04

SOME INTERESTING OBSERVATIONS 11/2/04

GOOD NEWS FROM CURIS, VERTEX, VICURON AND OTHERS 11/1/04

NEWS THAT WE HAVE BEEN WAITING FOR 10/28/04

GOOD NEWS THAT DARED TO PUP UP 10/25/04

GENZ YME REPORT AND CURIS TREAURE 10/20/04

GOOD NEWS FROM CYTOGEN AND deCODE  10/19/04

TRIALS, ERRORS AND GREAT DISCOVERIES 10/19/04

ELAN, AMGEN, CRUCELL, TRIMERIS 10/18/04

SLE, MALARIA AND MS  10/15/04

CHIRON, RENOVIS, INAMED 10/14/04

GOOD NEWS AND BAD NEWS 10/13/04

LIGHT  10/12/04

CHIRON, MEDIMMUNE AND GENVEC 10/8/04

GENENTECH, STILL KING AND ..10/7/04

YESTERDAY, TOMORROW AND AFTER TOMORROW 10/6/04

MEDX, CYTO, XOMA 10/5/04

TELIK AND AMGEN: EXCELLENT CLINICAL RESULTS 10/4/04

FIRMS TO WATCH AND OTHERS TO APPLAUD 10/1/04

BIOGEN IDEC, BIOMIRA AND ONYX 9/29/04

OXiGENE, CARDIOME AND PROMISES 9/28/04

NASTECH'S OBESITY DRUG  9/27/04

DNA, XOMA, EMISPHERE  9/24/04

NEWS FOR AMGEN AND GENAISSANCE 9/ 23/ 04

HYBRIDON, INTROGEN, CRUCELL  8/31/04

THE IMPACT 8/27/04

NEWS  8/25/04

MEDAREX' MELANOMA DRUG  8/23/04

AT A GLANCE 8/18/04

XOMA'S ACNE GEL  8/17/04

# ONE AND # TWO BIOTECH COMPANIES   8/16/04

CYTOGEN QUARTERLY REPORT 8/5/04

HYBRIDON 8/4/04

GILEAD, INTROGEN AND THE MARKET  8/4/04

AMGEN, GILEAD AND OTHER NEWS   7/30/04

 GENVEC: A PROMISING HIV VACCINE 7/29/04

BIIB, ELN, CRXA, AMLN  7/27/04

SCAM CONTINUES TO UNFOLD  7/26/04

MLNM AND AMGN  7/23/04

ELAN AND ALZHEIMER'S DISEASE  7/22/04

VERTEX, SEPRACOR, TRANSKARYOTIC  7/16/04

ELAN, CYTOMEDICS, CELERA  7/14/04

VERTEX' GOOD NEWS   7/13/04

GENENTECH, XOMA AND BIOGENTECH  7/8/04

 PALATIN FDA APPROVAL         7/6/04

NVO, BIIB, ELN, DCGN, CRXL    6/28/04

CYTOGEN AND COMBIDEX     6/25/04

XOMA, AMGN, COMRF.OB, MEDAREX AND CURAGEN  6/25/04

DENDREON AND OTHER NEWS  6 23 B 04

VERTEX: GREAT NEWS AND OTHER NEWS   6/23/04

CANCER DRUGS AND OTHER NEWS  6/21/04

GOOD NEWS AND BAD NEWS                6/14/04

CARDIOME, INVITROGEN, GENTA AND ... 6/1/04

APHTON AND OTHER NEWS  5/28

SALIX, CHIRON, GENITOPE, MEDAREX   5/27/04

SYNOPSIS                            5/26/04

BIIB, ELN, VRTX, SUPG       5/25/04

GENETRONICS , VICAL AND SCICLONE   5/24/04

ENZON, ILEX, LYNX, ACCELRYX   5/21/2004

MYELODYSPLASTIC SYNDROME (MDS): PHARMION'S DRUG APPROVED 5/20/2004